India will receive a share of 80 million US vaccines through COVAX: Official

On June 2, President Biden announced that the US will allocate 75 percent - nearly 1.9 crores of the first tranche of 2.5 crore doses - of unused COVID-19 vaccines from its stockpile through the UN-backed COVAX global vaccine sharing programme to countries in South and Southeast Asia as well as Africa.

PTI
June 10, 2021 / 01:06 PM IST

Source: AP

India will be receiving a share of the 80 million (8 crores) unused COVID-19 vaccines through the UN-backed COVAX global vaccine sharing programme that President Joe Biden has announced, according to a senior State Department official.

On June 2, President Biden announced that the US will allocate 75 percent - nearly 1.9 crores of the first tranche of 2.5 crore doses - of unused COVID-19 vaccines from its stockpile through the UN-backed COVAX global vaccine sharing programme to countries in South and Southeast Asia as well as Africa.

The move is part of his administration's framework for sharing 80 million (8 crores) vaccines globally by the end of June.

Follow our LIVE blog for latest updates of the novel coronavirus pandemic

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

According to a White House fact sheet, nearly 19 million vaccines will be shared through COVAX.

“I don't have the specific details on when the shipment of vaccines will be arriving in India. Of course, India will be in receipt of a share of those 80 million vaccines and through COVAX, I believe there were some six million vaccines destined for the region,” State Department Spokesperson Ned Price told reporters at a news conference on Wednesday.

COVID-19 Vaccines Global Access, abbreviated as COVAX, is a worldwide initiative aimed at equitable access to COVID-19 vaccines directed by Gavi, the Vaccine Alliance, the Coalition for Epidemic Preparedness Innovations, and the World Health Organisation.

“We know that India has suffered tremendously with this pandemic and as we have done in the case of these vaccines, but also as we did even prior to this vaccine sharing announcement. We have demonstrated our commitment to work closely with our partners in India to help see the way out of this epidemic,” he said.

In recent weeks, the US has so far supplied seven planeloads of life-saving supplies worth approximately USD 100 million.

“This is also in addition to the tremendous generosity that we have seen from the private sector and the diaspora here in this country that has donated some 400 million additional dollars. So, that's half a billion dollars that the United States government and the people here in the United States have committed to help our friends and to help our partners in India recover from this pandemic,” Price said.

Responding to a question, he said the Biden administration is absolutely continuing with its commitment to help the government and the people of India emerge from this pandemic.

“We remain engaged with the private sector as we have spoken of our commitment of vaccines to India, of our commitment of planeloads of life-saving supplies, doing all we can not only on our part but also to galvanize action on the part of other non-governmental actors here in the United States to help our friends in India,” Price said.

India is currently witnessing the second wave of the COVID-19 pandemic. So far, the country has recorded over 2,90,89,069 confirmed COVID-19 cases, including 3,53,528 deaths.

The Biden administration had been under pressure to send the excess COVID-19 vaccines with the US to nations like India, which are facing severe vaccine shortages.

Follow our full coverage of the coronavirus pandemic here.
PTI
TAGS: #coronavirus #COVAX #COVID-19 vaccine #Health #India #United States
first published: Jun 10, 2021 12:59 pm